BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1713070)

  • 21. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.
    Beck SD; Patel MI; Sheinfeld J
    J Urol; 2004 Jan; 171(1):168-71. PubMed ID: 14665869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
    Grinevich IuA; Tatarinov IuS; Iugrinova LG; Olefirenko GA; Dotsenko IuS
    Vopr Onkol; 1981; 27(12):19-23. PubMed ID: 6275607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human chorionic gonadotropin in esophageal carcinomas. An immunohistochemical study.
    Trias I; Campo E; Benasco C; Palacin A; Cardesa A
    Pathol Res Pract; 1991 May; 187(4):503-7. PubMed ID: 1652131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Placental proteins in high-grade urothelial neoplasms. An immunohistochemical study of human chorionic gonadotropin, human placental lactogen, and pregnancy-specific beta-1-glycoprotein.
    Campo E; Algaba F; Palacin A; Germa R; Sole-Balcells FJ; Cardesa A
    Cancer; 1989 Jun; 63(12):2497-504. PubMed ID: 2655871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor markers in testicular germ cell tumors related to the stage of the disease at the time of diagnosis.
    Jacobsen GK
    Oncodev Biol Med; 1983; 4(6):C39-44. PubMed ID: 6196749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular localization of AFP, hCG and its free subunits, and SP1 in embryonal carcinoma of the testis and ovary.
    Furumoto M
    Pathol Res Pract; 1981 Dec; 173(1-2):12-21. PubMed ID: 6174958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sense and nonsense of tumor markers in practice].
    Joss R; Cerny T
    Schweiz Med Wochenschr; 1990 May; 120(19):693-703. PubMed ID: 1693445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
    Cole LA; Sutton JM
    J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidelines following hydatidiform mole: a reappraisal.
    Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor markers in testicular cancer.
    Catalona WJ
    Urol Clin North Am; 1979 Oct; 6(3):613-28. PubMed ID: 92089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical use of HCG and hCG beta determinations.
    Mann K; Saller B; Hoermann R
    Scand J Clin Lab Invest Suppl; 1993; 216():97-104. PubMed ID: 7690985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Placental and embryonal proteins as antigens in the immunodiagnosis of malignant tumors].
    Tatarinov IuS
    Vestn Akad Med Nauk SSSR; 1977; (10):90-3. PubMed ID: 72463
    [No Abstract]   [Full Text] [Related]  

  • 35. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
    Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of alpha 1-fetoprotein and beta-human chorionic gonadotropin in infancy and childhood.
    Schneider DT; Calaminus G; Göbel U
    Pediatr Hematol Oncol; 2001; 18(1):11-26. PubMed ID: 11205836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunohistochemical localization of hCG alpha, hCG beta CTP, hPL and SP1 on villous and extravillous trophoblasts in normal human pregnancy].
    Sasagawa M; Yamazaki T; Sudo Y; Kanazawa K; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1073-9. PubMed ID: 3302072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood test for placental site trophoblastic tumor and nontrophoblastic malignancy for evaluating patients with low positive human chorionic gonadotropin results.
    Cole LA; Khanlian SA; Muller CY
    J Reprod Med; 2008 Jul; 53(7):457-64. PubMed ID: 18720919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncofetal and oncoplacental antigens as tumor markers.
    Yamauchi S; Miyake H
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):95-109. PubMed ID: 2463397
    [No Abstract]   [Full Text] [Related]  

  • 40. [Usefulness of tumor markers in the treatment of germ cell tumors].
    Germá Lluch JR; García del Muro X; Galán MC
    Arch Esp Urol; 2000; 53(6):460-8. PubMed ID: 11002513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.